Markwalter Chester E, Pagels Robert F, Wilson Brian K, Ristroph Kurt D, Prud'homme Robert K
J Vis Exp. 2019 Jan 7(143). doi: 10.3791/58757.
The formulation of a therapeutic compound into nanoparticles (NPs) can impart unique properties. For poorly water-soluble drugs, NP formulations can improve bioavailability and modify drug distribution within the body. For hydrophilic drugs like peptides or proteins, encapsulation within NPs can also provide protection from natural clearance mechanisms. There are few techniques for the production of polymeric NPs that are scalable. Flash NanoPrecipitation (FNP) is a process that uses engineered mixing geometries to produce NPs with narrow size distributions and tunable sizes between 30 and 400 nm. This protocol provides instructions on the laboratory-scale production of core-shell polymeric nanoparticles of a target size using FNP. The protocol can be implemented to encapsulate either hydrophilic or hydrophobic compounds with only minor modifications. The technique can be readily employed in the laboratory at milligram scale to screen formulations. Lead hits can directly be scaled up to gram- and kilogram-scale. As a continuous process, scale-up involves longer mixing process run time rather than translation to new process vessels. NPs produced by FNP are highly loaded with therapeutic, feature a dense stabilizing polymer brush, and have a size reproducibility of ± 6%.
将治疗性化合物制成纳米颗粒(NPs)可赋予其独特性质。对于水溶性差的药物,NP制剂可提高生物利用度并改变药物在体内的分布。对于肽或蛋白质等亲水性药物,包封在NP内还可免受自然清除机制的影响。可扩展的聚合物NP生产技术很少。快速纳米沉淀法(FNP)是一种利用工程混合几何结构来生产尺寸分布窄且尺寸在30至400nm之间可调的NP的方法。本方案提供了使用FNP在实验室规模生产目标尺寸的核壳聚合物纳米颗粒的指导说明。只需进行少量修改,该方案即可用于包封亲水性或疏水性化合物。该技术可在实验室以毫克规模轻松用于筛选制剂。先导化合物可直接扩大到克级和千克级。作为一个连续过程,扩大规模涉及更长的混合过程运行时间,而不是转换到新的工艺容器。通过FNP生产的NP负载大量治疗剂,具有致密的稳定聚合物刷,尺寸重现性为±6%。